US approves first new Alzheimer’s drug in 20 years

Life Hacks

In March 2019, late-stage international trials of aducanumab, involving about 3,000 patients, were halted when analysis showed it was no better, given as a monthly infusion, at slowing the deterioration of memory and thinking problems than a dummy drug.

Leave a Reply

Your email address will not be published. Required fields are marked *